Compare Equinor ASA (EQNR) vs Eli Lilly And Co (LLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Equinor ASA vs Eli Lilly And Co — how do they compare? Equinor ASA trades at $40.98 (market cap $97.58B), while Eli Lilly And Co trades at $1,211.58 (market cap $1.08T). The key difference: Eli Lilly And Co is far larger — about 11.1× Equinor ASA's market cap, and Equinor ASA pays the higher dividend (3.81%). Which is the better fit depends on your goals.
| EQNR | LLY | |
|---|---|---|
Market Cap | $97.58B | $1.08T |
Sector | Energy | Health |
52-Week High | $42.40 | $1.24K |
52-Week Low | $22.41 | $639.43 |
Enterprise Value | $106.28B | $1.13T |
Dividend Yield | 3.81% | 0.57% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2021 (52% oil) and ended the year with 5.4 billion barrels of proven reserves (49% oil). Operations also include offshore wind, solar, oil refineries and natural gas processing, marketing, and trading.
Read more on EQNR →About Eli Lilly And Co
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →
